Phathom Price To Free Cash Flows Ratio from 2010 to 2024
| PHAT Stock | USD 8.87 0.10 1.11% |
Price To Free Cash Flows Ratio | First Reported 2010-12-31 | Previous Quarter (3.36) | Current Value (3.53) | Quarterly Volatility 101.03706743 |
Check Phathom Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phathom Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 8.3 M, Depreciation And Amortization of 603.8 K or Interest Expense of 44.1 M, as well as many indicators such as Price To Sales Ratio of 549, Dividend Yield of 0.0 or Days Sales Outstanding of 701. Phathom financial statements analysis is a perfect complement when working with Phathom Pharmaceuticals Valuation or Volatility modules.
Phathom | Price To Free Cash Flows Ratio |
Latest Phathom Pharmaceuticals' Price To Free Cash Flows Ratio Growth Pattern
Below is the plot of the Price To Free Cash Flows Ratio of Phathom Pharmaceuticals over the last few years. It is Phathom Pharmaceuticals' Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phathom Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Price To Free Cash Flows Ratio | 10 Years Trend |
|
Price To Free Cash Flows Ratio |
| Timeline |
Phathom Price To Free Cash Flows Ratio Regression Statistics
| Arithmetic Mean | (126.62) | |
| Coefficient Of Variation | (79.79) | |
| Mean Deviation | 95.59 | |
| Median | (206.28) | |
| Standard Deviation | 101.04 | |
| Sample Variance | 10,208 | |
| Range | 203 | |
| R-Value | 0.86 | |
| Mean Square Error | 2,928 | |
| R-Squared | 0.73 | |
| Significance | 0.000046 | |
| Slope | 19.35 | |
| Total Sum of Squares | 142,919 |
Phathom Price To Free Cash Flows Ratio History
About Phathom Pharmaceuticals Financial Statements
Phathom Pharmaceuticals shareholders use historical fundamental indicators, such as Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although Phathom Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Phathom Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Phathom Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Free Cash Flows Ratio | (3.36) | (3.53) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.